Published in Ann Pharmacother on April 22, 2008
Advancing the science for active surveillance: rationale and design for the Observational Medical Outcomes Partnership. Ann Intern Med (2010) 4.32
Empirical assessment of methods for risk identification in healthcare data: results from the experiments of the Observational Medical Outcomes Partnership. Stat Med (2012) 3.26
Systematic review of the incidence and characteristics of preventable adverse drug events in ambulatory care. Ann Pharmacother (2007) 2.99
The cost of health care for children and adults with sickle cell disease. Am J Hematol (2009) 2.66
Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc (2011) 2.65
Validity and reliability of measurement instruments used in research. Am J Health Syst Pharm (2008) 2.64
Independent pharmacist prescribing in Canada. Can Pharm J (Ott) (2012) 2.20
Re-using Mini-Sentinel data following rapid assessments of potential safety signals via modular analytic programs. Pharmacoepidemiol Drug Saf (2013) 2.01
Evaluating the impact of database heterogeneity on observational study results. Am J Epidemiol (2013) 1.83
Stimulants and cardiovascular events in youth with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (2011) 1.80
Nature of preventable adverse drug events in hospitals: a literature review. Am J Health Syst Pharm (2003) 1.69
Cost-effectiveness of respiratory syncytial virus prophylaxis in various indications. Arch Pediatr Adolesc Med (2011) 1.68
Risk of venous thromboembolism in women with polycystic ovary syndrome: a population-based matched cohort analysis. CMAJ (2012) 1.55
Collaborative practice in health systems change: the Nova Scotia experience with the Strengthening Primary Care Initiative. Nurs Leadersh (Tor Ont) (2004) 1.50
Causes of hyperglycemia and hypoglycemia in adult inpatients. Am J Health Syst Pharm (2005) 1.48
The effects of prophylactic iron given in prenatal supplements on iron status and birth outcomes: a randomized controlled trial. Am J Obstet Gynecol (2006) 1.47
A Comparative Assessment of Observational Medical Outcomes Partnership and Mini-Sentinel Common Data Models and Analytics: Implications for Active Drug Safety Surveillance. Drug Saf (2015) 1.45
Effects of concomitant amiodarone and haloperidol on Q-Tc interval prolongation. Am J Health Syst Pharm (2008) 1.41
Small budget impact is a result of flawed assumptions and ignores questionable cost-effectiveness for RSV prophylaxis. Value Health (2010) 1.39
Disability measures in stroke: relationship among the Barthel Index, the Functional Independence Measure, and the Modified Rankin Scale. Stroke (2004) 1.39
The roles of teaching hospitals, insurance status, and race/ethnicity in receipt of adjuvant therapy for regional-stage breast cancer in Florida. Am J Public Health (2005) 1.30
Defining a reference set to support methodological research in drug safety. Drug Saf (2013) 1.28
Pill count adherence to prenatal multivitamin/mineral supplement use among low-income women. J Nutr (2005) 1.25
Association Between Incretin-Based Drugs and the Risk of Acute Pancreatitis. JAMA Intern Med (2016) 1.21
Correction for errors in measuring adherence to prenatal multivitamin/mineral supplement use among low-income women. J Nutr (2006) 1.14
Bridging islands of information to establish an integrated knowledge base of drugs and health outcomes of interest. Drug Saf (2014) 1.13
A comparison of the empirical performance of methods for a risk identification system. Drug Saf (2013) 1.12
The role of health-related quality of life in early discontinuation of chemotherapy for breast cancer. Breast J (2007) 1.09
Determinants of initial pharmacological treatment for youths with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol (2009) 1.05
Assessing the association between omalizumab and arteriothrombotic events through spontaneous adverse event reporting. J Asthma Allergy (2012) 1.01
Discordance between availability of pharmacogenetics studies and pharmacogenetics-based prescribing information for the top 200 drugs. Ann Pharmacother (2006) 1.00
Risk of acute kidney injury associated with the use of fluoroquinolones. CMAJ (2013) 0.98
Prophylactic nesiritide does not prevent dialysis or all-cause mortality in patients undergoing high-risk cardiac surgery. J Thorac Cardiovasc Surg (2009) 0.97
Palivizumab utilization and compliance: trends in respiratory syncytial virus prophylaxis in Florida. J Pediatr (2010) 0.94
Attitudinal factors among adult prescription recipients associated with choice of where to be vaccinated. J Clin Epidemiol (2002) 0.93
Polypharmacy in attention deficit hyperactivity disorder treatment: current status, challenges and next steps. Curr Psychiatry Rep (2012) 0.92
An in-depth analysis of medication errors in hospitalized patients with HIV. Ann Pharmacother (2011) 0.92
Activated partial thromboplastin time versus antifactor Xa heparin assay in monitoring unfractionated heparin by continuous intravenous infusion. Ann Pharmacother (2011) 0.91
Impact of a criteria-based reimbursement policy on the use of respiratory drugs delivered by nebulizer and health care services utilization in Nova Scotia, Canada. Pharmacotherapy (2005) 0.90
An algorithm to identify preterm infants in administrative claims data. Pharmacoepidemiol Drug Saf (2012) 0.89
Effect of educational and policy interventions on institutional utilization of wet nebulization respiratory drugs and portable inhalers. Can J Clin Pharmacol (2008) 0.89
Medication persistence rates and factors associated with persistence in patients following stroke: a cohort study. BMC Neurol (2008) 0.87
Ethnic differences in the reliability and validity of a Panic Disorder Screen. Ethn Health (2007) 0.86
Patient counseling practices in U.S. pharmacies: effects of having pharmacists hand the medication to the patient and state regulations on pharmacist counseling. J Am Pharm Assoc (2003) (2011) 0.86
Male breast cancer and 5α-reductase inhibitors finasteride and dutasteride. J Urol (2013) 0.86
Pharmacoeconomic modeling of nesiritide versus dobutamine for decompensated heart failure. Pharmacotherapy (2006) 0.85
Efficacy and safety of oral phenylephrine: systematic review and meta-analysis. Ann Pharmacother (2007) 0.85
Labor costs associated with incontinence in long-term care facilities. Urology (2003) 0.84
The geographic accessibility of pharmacies in Nova Scotia. Can Pharm J (Ott) (2013) 0.83
Cost-utility analysis of rimonabant in the treatment of obesity. Value Health (2007) 0.83
Risk drinking behavior among psychotropic drug users in an aging Finnish population: the FinDrink study. Alcohol (2008) 0.83
Antihypertensive drug class interactions and risk for incident diabetes: a nested case-control study. J Am Heart Assoc (2013) 0.83
Pharmacists' participation in an inhaled respiratory medication program: reimbursement of professional fees. Ann Pharmacother (2005) 0.82
Pre-existing cardiovascular conditions and pharmacological treatment of adult ADHD. Pharmacoepidemiol Drug Saf (2010) 0.82
Automated medication error studies with audit supplementation were effectively designed and analyzed by time series. J Clin Epidemiol (2006) 0.81
Planning for pharmacy health information technology in critical access hospitals. Am J Health Syst Pharm (2007) 0.81
Variation in choice of study design: findings from the Epidemiology Design Decision Inventory and Evaluation (EDDIE) survey. Drug Saf (2013) 0.81
Hydroxyurea use in patients with sickle cell disease in a Medicaid population. Am J Hematol (2011) 0.81
Projecting the effect of nesiritide on dialysis and hospital mortality in cardiac surgery patients. Value Health (2010) 0.80
Pharmacy-specific quality indicators for asthma therapy. Res Social Adm Pharm (2005) 0.80
The impact of statins on health services utilization and mortality in older adults discharged from hospital with ischemic heart disease: a cohort study. BMC Health Serv Res (2009) 0.80
Patients' views of priority setting for new medicines. A qualitative study of patients with rheumatoid arthritis. Scand J Rheumatol (2002) 0.80
Population prevalence of high dose paracetamol in dispensed paracetamol/opioid prescription combinations: an observational study. BMC Clin Pharmacol (2012) 0.79
Development and evaluation of a patient empowerment video to promote hydroxyurea adoption in sickle cell disease. J Natl Med Assoc (2009) 0.79
Lives in isolation: stories and struggles of low-income African American women with panic disorder. CNS Neurosci Ther (2009) 0.79
An evaluation of the effects of gatifloxacin on glucose homeostasis. Pharm World Sci (2008) 0.79
Patient understanding of drug risks: an evaluation of medication guide assessments. Pharmacoepidemiol Drug Saf (2015) 0.78
Comparing marginal structural models to standard methods for estimating treatment effects of antihypertensive combination therapy. BMC Med Res Methodol (2012) 0.78
Trends in oral antihyperglycemic and insulin use in the Nova Scotia senior population (1993-1999). Can J Clin Pharmacol (2002) 0.77
Associations between aspirin and other non-steroidal anti-inflammatory drugs and aortic valve or coronary artery calcification: the Multi-Ethnic Study of Atherosclerosis and the Heinz Nixdorf Recall Study. Atherosclerosis (2013) 0.77
Coping strategies used by patients infected with hepatitis C virus who are facing medication costs. Can J Hosp Pharm (2011) 0.76
Effectiveness of nesiritide on dialysis or all-cause mortality in patients undergoing cardiothoracic surgery. Clin Cardiol (2006) 0.76
Medication safety infrastructure in critical-access hospitals in Florida. Am J Health Syst Pharm (2006) 0.76
Anti-diabetic drug utilization of pregnant diabetic women in us managed care. BMC Pregnancy Childbirth (2014) 0.76
Pharmacotherapy for incident attention-deficit/hyperactivity disorder: practice patterns and quality metrics. Curr Med Res Opin (2014) 0.76
RE: Drug risk assessment and data reuse. Pharmacoepidemiol Drug Saf (2014) 0.75
Intensive glucose lowering and cardiovascular outcomes. N Engl J Med (2011) 0.75
Effect of utilization policies for fluoroquinolones: a pilot study in nova scotia hospitals. Can J Hosp Pharm (2009) 0.75
Pediatric exclusivity: evolving legislation and novel complexities within pediatric therapeutic development. Ann Pharmacother (2013) 0.75
Transfusion practices in the management of sickle cell disease: a survey of Florida hematologists/oncologists. ISRN Hematol (2012) 0.75
Response to Letter to the editor regarding Sensorineural hearing loss associated with neomycin eardrops and nonintact tympanic membranes. Otolaryngol Head Neck Surg (2013) 0.75
Response to comment on 'empirical assessment of methods for risk identification in healthcare data'. Stat Med (2013) 0.75
Response to respiratory synctial virus. South Med J (2008) 0.75
Topical dexamethasone and tympanic membrane perforation healing in otitis media: a short-term study. Otol Neurotol (2010) 0.75
Development of a Medication Safety and Quality Survey for Small Rural Hospitals. J Patient Saf (2017) 0.75
Topical corticosteroid prescribing patterns following changes in drug benefit status. Ann Pharmacother (2003) 0.75
Epidemiology of Persistent Tympanic Membrane Perforations Subsequent to Tympanostomy Tubes Assessed With Real World Data. Otol Neurotol (2016) 0.75
Erratum to: A Comparative Assessment of Observational Medical Outcomes Partnership and Mini-Sentinel Common Data Models and Analytics: Implications for Active Drug Safety Surveillance. Drug Saf (2015) 0.75
Perioperative medication errors in otolaryngology. Laryngoscope (2010) 0.75
Negative Results Do Not Imply Absence of Ototoxicity with Middle Ear Application of Neomycin. Otolaryngol Head Neck Surg (2014) 0.75
A tool kit for practice-based research. Am J Health Syst Pharm (2008) 0.75
Consistency of psychotropic drug-drug interactions listed in drug monographs. J Am Pharm Assoc (2003) (2017) 0.75
Analyzing international prescribing patterns and medication use: an approach to assisting in the improvement of health care quality and patient outcomes. Clin Ther (2007) 0.75
Polycystic ovary syndrome and combined oral contraceptive use: a comparison of clinical practice in the United States to treatment guidelines. Gynecol Endocrinol (2013) 0.75
Methodological Concerns Regarding Cost-effectiveness Analysis of Palivizumab in Florida Medicaid-Reply. Arch Pediatr Adolesc Med (2012) 0.75